InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Bingham Kate, 董事. Director active across 1 company, notably BICYCLE THERAPEUTICS plc. Aggregated, 2 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €33k. History available since 13 July 2021. The latest transaction was filed on 13 July 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Bingham Kate
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
588 股@ US$33.500.0034% mcap25.0% 占其流量Ordinary SharesSEC:0000899243-21-028984:0
588 股@ US$33.50100.0% 占其流量Ordinary SharesSEC:0000899243-21-028546:0
2 条申报中的 2 条
About Bingham Kate
Kate Bingham serves as a Director for Bicycle Therapeutics plc. She brings expertise in biotechnology and product development to the board. Her experience in the healthcare sector enables her to contribute to the company's strategy and guide key decisions.
